Kodak (KODK) Q2 2026 earnings review
Growth Accelerates and Profitability Reverses Positively
Kodak delivered a breakout quarter, with revenue growth accelerating to 18% YoY ($311M). Unlike previous quarters bogged down by non-cash pension adjustments and derivative losses, GAAP Net Income is reversing, flipping from a $26M loss a year ago to a $17M profit. Gross margins expanded by 700 basis points to 26%, proving the company's pricing power can offset severe commodity inflation. The Advanced Materials & Chemicals (AM&C) segment was the star, surging 40% YoY, confirming management's long-term pivot from stabilization to active growth.
🐂 Bull Case
The AM&C segment is no longer just a narrative; it is delivering hard numbers. A 40% YoY revenue jump to $105M shows that investments in industrial films, chemicals, and new applications are yielding substantial, high-margin growth.
Despite management explicitly calling out higher silver and aluminum prices, gross profit margin expanded from 19% to 26%. The ability to pass costs through to customers and drive operational efficiencies is a massive positive.
🐻 Bear Case
Inventory increased by another $37M this quarter, driven by rising commodity prices (silver and aluminum). This follows a $38M increase in Q1, severely tying up working capital.
Management continues to withhold quantitative forward guidance, and the absence of a Q&A session deprives investors of clarity on how much of Q2's AM&C surge is recurring versus one-time pipeline filling.
⚖️ Verdict: 🟢
Bullish. Kodak has definitively crossed the threshold from a complex balance sheet restructuring story into a genuine growth and operational leverage story. Generating $36M in Operational EBITDA while absorbing major commodity hits is highly impressive.
Key Themes
Advanced Materials & Chemicals (AM&C) Accelerating
AM&C is accelerating rapidly, moving from steady growth to a 40% YoY revenue explosion ($105M vs $75M). Operational EBITDA for the segment nearly tripled from $8M to $22M. This validates the strategic investments made in the cGMP pharmaceutical facility and direct-to-consumer film distribution.
Core Print Business Remains Resilient
The Print segment, historically viewed as a declining legacy asset, is stable and growing. Revenues increased 10% YoY to $195M, and Operational EBITDA flipped from a $4M loss a year ago to an $8M profit. The launch of the Sonora Ultra XR plate and full production of the PROSPER 520 digital press are driving this turnaround.
Aggressive Deleveraging via KRIP Repayments
The multi-year balance sheet restructuring is paying off in real-time. Kodak used proceeds from the Kodak Retirement Income Plan (KRIP) reversion to execute a $101M repayment on its Term Loans this quarter. Total long-term debt is now down to $108M, vastly decreasing future interest burdens (interest expense fell from $15M in 25Q2 to $6M in 26Q2).
Inventory Trapped by Commodity Inflation
A key concern contradicting the strong cash flow narrative is the balance sheet's inventory line. Inventories sit at $253M, up $37M from December 2025. Management explicitly blames rising silver and aluminum prices. If commodity prices reverse or demand slows, this inventory could lead to write-downs.
Macro: Insulation via U.S. Manufacturing
As geopolitical tensions and tariff threats escalate globally, Kodak's position as the only U.S. manufacturer of lithographic plates provides a unique competitive moat. While tariffs can disrupt supply chains, Kodak's localized production base may allow it to capture domestic market share from foreign competitors facing import duties.
Other KPIs
Accelerating. Up from 19% in the prior year quarter. A 61% YoY increase in absolute gross profit dollars ($82M vs $51M) proves that volume growth is being combined with excellent unit economics and cost absorption.
Decreased by $47M from December 31, 2025. However, this is a 'good' decrease, primarily driven by a highly accretive $101M debt repayment. Operating cash flow inherently improved by $5M compared to the prior year.
Guidance
Accelerating past targets. Management previously guided to reduce term debt to $200M using KRIP proceeds. With the $101M repayment this quarter, long-term debt (net of current portion) currently sits at $108M, significantly outperforming their original target timeline.
Key Questions
AM&C Sustainability
The AM&C segment grew 40% YoY. How much of this growth is driven by recurring, long-term contracts (like Pharma production) versus cyclical spikes or one-time inventory channel fills in industrial films?
Inventory Management Strategy
With inventories ballooning by over $35M year-to-date due to silver and aluminum costs, at what point does management plan to normalize these levels, and what hedging strategies are in place if raw material prices remain elevated?
Capital Allocation Post-Deleveraging
Now that term debt has been aggressively paid down to ~$110 million and the balance sheet is net-cash positive, what is the priority for the $290M cash balance? Are M&A, dividends, or accelerated R&D the primary focus for 2027?